Clinical Trial Update: The Effect of IV Cangrelor and Oral Ticagrelor Study [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effects of intravenous cangrelor and oral ticagrelor in acute coronary syndrome and its subtypes, completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• St-elevation Myocardial Infarction
• Unstable Angina

Drugs mentioned

• Cangrelor (Kengreal) (cangrelor)
• ticagrelor (Brilinta) (ticagrelor)

Snippet

Sponsor: The Royal Wolverhampton Hospitals NHS Trust | Conditions: Acute Coronary Syndrome (ACS), High On-treatment Platelet Reactivity (HTPR) | Phase 4 | Status: COMPLETED | Results posted: 2025-05-02